Extravasation
Extravasation is the process by which cancer cells exit blood vessels to invade surrounding tissues and spread throughout the body.
Extravasation is the process by which a tumor cell that has arrested within the vasculature of a distant organ crosses the vessel wall outward, moving from the blood-facing side of the endothelium into the surrounding tissue, marking the point at which a circulating tumor cell re-enters solid tissue at a new anatomical location.
Prerequisite Conditions
Stable Vascular Arrest
Extravasation can only proceed once a tumor cell has achieved a sufficiently stable position within the vessel, since a cell still being swept along by blood flow lacks the necessary contact time with the vessel wall to initiate crossing.
Local Endothelial Permissiveness
The degree to which extravasation can proceed depends on the permeability and structural characteristics of the endothelium at the specific arrest site, with more permissive or already-compromised vessel segments allowing easier passage.
Mechanisms of Barrier Crossing
Paracellular Passage
In this mode, the tumor cell moves through the space between two adjacent endothelial cells, requiring a transient loosening of the junctions that normally hold those cells together.
Transcellular Passage
Alternatively, a tumor cell can cross directly through the body of a single endothelial cell, forming a temporary channel through that cell's cytoplasm rather than passing between separate cells.
Endothelial Retraction
In some cases, extravasation is facilitated by active retraction or contraction of endothelial cells at the site of tumor cell contact, widening gaps in the vessel lining and easing passage.
Signaling Interactions Driving Extravasation
Tumor Cell to Endothelium Communication
Arrested tumor cells actively signal to nearby endothelial cells, promoting localized changes in junction stability and cytoskeletal organization that facilitate the cell's passage across the barrier.
Platelet and Immune Cell Contribution
Platelets and certain immune cell types associated with the arrested tumor cell can contribute additional signals that further destabilize local endothelial junctions, assisting the extravasation process.
Basement Membrane Remodeling
Beyond the endothelial layer itself, the underlying basement membrane must also be locally degraded or remodeled, a step often accomplished through enzymatic activity associated with the extravasating cell or its immediate surroundings.
Post-Crossing Positioning
Perivascular Localization
Immediately following extravasation, tumor cells are frequently found in close proximity to the vessel from which they emerged, reflecting the short distance initially traveled during the crossing process.
Transition to Tissue-Resident Behavior
Once outside the vessel, the tumor cell must shift from behaviors suited to circulation and barrier crossing toward behaviors suited to surviving and interacting within a new solid tissue environment.
Distinguishing Extravasation from Related Processes
Extravasation Versus Intravasation
Extravasation and intravasation both involve crossing the vessel wall, but in opposite directions: intravasation moves a cell from tissue into a vessel, while extravasation moves a cell from within a vessel back into tissue.
Extravasation Versus Colonization
Successfully crossing the vessel wall does not by itself guarantee that a tumor cell will survive or proliferate in its new location; colonization is a distinct and subsequent process that depends on additional adaptive capacities beyond the mechanics of barrier crossing.
Significance Within the Metastatic Sequence
Final Vascular Barrier
Extravasation represents the last physical vascular barrier a disseminating tumor cell must overcome before it can attempt to establish itself at a distant site, following intravasation, circulatory survival, and vascular arrest.
Rate-Limiting Contribution to Metastatic Efficiency
Because barrier crossing again requires specific and coordinated cellular changes, extravasation is considered one of several steps at which the overall efficiency of the metastatic process can be substantially constrained.